Stock Analysis
- United States
- /
- Life Sciences
- /
- NasdaqCM:NOTV
Inotiv Third Quarter 2024 Earnings: Misses Expectations
Inotiv (NASDAQ:NOTV) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$105.8m (down 33% from 3Q 2023).
- Net loss: US$26.1m (down from US$1.84m profit in 3Q 2023).
- US$1.00 loss per share (down from US$0.072 profit in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Inotiv Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 20%.
Looking ahead, revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Life Sciences industry in the US.
Performance of the American Life Sciences industry.
The company's shares are down 11% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Inotiv (1 is a bit unpleasant) you should be aware of.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:NOTV
Inotiv
Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries.